Scisparc Ltd
SPRC3.060USD
-0.260-7.83%
Close 11/04, 16:00（ET）Quotes delayed by 15 min
152.87KMarket Cap
LossP/E TTM
More Details of Scisparc Ltd Company
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Scisparc Ltd Info
Ticker SymbolSPRC
Company nameScisparc Ltd
IPO dateDec 22, 2021
CEOMr. Amitay Weiss
Number of employees2
Security typeOrdinary Share
Fiscal year-endDec 22
Address20 Raul Wallenberg Street, Tower A
CityTEL AVIV-YAFO
Stock exchangeNASDAQ Capital Market Consolidated
CountryIsrael
Postal code6971916
Phone97236103100
Websitehttps://scisparc.com/
Ticker SymbolSPRC
IPO dateDec 22, 2021
CEOMr. Amitay Weiss
Company Executives of Scisparc Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Itschak Shrem
Mr. Itschak Shrem
Chairman of the Board
Chairman of the Board
16.00
+128.57%
Mr. Amitay Weiss
Mr. Amitay Weiss
Chief Executive Officer, Director
Chief Executive Officer, Director
1.00
--
Prof. Ari Shamiss, M.D.
Prof. Ari Shamiss, M.D.
Independent Director
Independent Director
--
--
Mr. Alon Dayan
Mr. Alon Dayan
Independent Director
Independent Director
--
--
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Amnon Shay
Mr. Amnon Shay
Independent Director
Independent Director
--
--
Mr. Moshe Revach
Mr. Moshe Revach
Director
Director
--
--
Mr. Lior Vider
Mr. Lior Vider
Independent Director
Independent Director
--
--
Ms. Liat Sidi
Ms. Liat Sidi
Director
Director
--
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Itschak Shrem
Mr. Itschak Shrem
Chairman of the Board
Chairman of the Board
16.00
+128.57%
Mr. Amitay Weiss
Mr. Amitay Weiss
Chief Executive Officer, Director
Chief Executive Officer, Director
1.00
--
Prof. Ari Shamiss, M.D.
Prof. Ari Shamiss, M.D.
Independent Director
Independent Director
--
--
Mr. Alon Dayan
Mr. Alon Dayan
Independent Director
Independent Director
--
--
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Amnon Shay
Mr. Amnon Shay
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Oct 18
Updated: Sat, Oct 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
UBS Financial Services, Inc.
0.20%
Yorkville Advisors Global, LP.
0.16%
Renaissance Technologies LLC
0.13%
Valley National Advisers Inc.
0.06%
Other
99.44%
Shareholders
Shareholders
Proportion
UBS Financial Services, Inc.
0.20%
Yorkville Advisors Global, LP.
0.16%
Renaissance Technologies LLC
0.13%
Valley National Advisers Inc.
0.06%
Other
99.44%
Shareholder Types
Shareholders
Proportion
Investment Advisor
0.27%
Investment Advisor/Hedge Fund
0.16%
Hedge Fund
0.13%
Other
99.44%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
15
9.04K
0.56%
+2.10K
2025Q2
20
5.89K
1.10%
-4.32K
2025Q1
22
123.94K
1.13%
-90.52K
2024Q4
22
186.52K
1.22%
-6.68K
2024Q3
20
179.36K
1.73%
+90.02K
2024Q2
22
138.03K
12.19%
+104.31K
2024Q1
20
67.89K
2.29%
+37.60K
2023Q4
19
11.96K
4.65%
-10.95K
2023Q3
23
5.71K
4.48%
-17.08K
2023Q2
22
12.21K
6.80%
-11.05K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
UBS Financial Services, Inc.
3.31K
0.2%
+3.31K
--
Jun 30, 2025
Yorkville Advisors Global, LP.
2.63K
0.16%
+2.63K
--
Feb 27, 2024
Renaissance Technologies LLC
2.07K
0.13%
+2.07K
--
Jun 30, 2025
SBI Securities Co., Ltd.
18.00
0%
+4.00
+28.57%
Jun 30, 2025
Shrem (Itschak)
16.00
0%
+9.00
+128.57%
Apr 23, 2025
Rhumbline Advisers Ltd. Partnership
1.00
0%
--
--
Jun 30, 2025
BofA Global Research (US)
2.00
0%
--
--
Jun 30, 2025
Weiss (Amitay)
1.00
0%
--
--
Apr 23, 2025
J.P. Morgan Securities LLC
--
0%
-22.00
-100.00%
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Sep 20, 2023
Merger
26→1
Sep 20, 2023
Merger
26→1
Sep 20, 2023
Merger
26→1
Sep 20, 2023
Merger
26→1
Date
Type
Ratio
Sep 20, 2023
Merger
26→1
Sep 20, 2023
Merger
26→1
Sep 20, 2023
Merger
26→1
Sep 20, 2023
Merger
26→1
